MK-801, NMDA RECEPTORS AND ISCHEMIA-INDUCED NEURODEGENERATION

[1] BENEVISTE H, 1984, J NEUROCHEM, V43, P1369

[2] BLOCK GA, 1987, J CEREB BLOOD FLOW M, V7, pS149

[3] BRIERLEY JB, 1984, GREENFIELDS NEUROPAT, P125

[4] CHOI D W, 1986, Society for Neuroscience Abstracts, V12, P381

[5] ANTICONVULSANT ACTIVITY OF (+)-5-METHYL-10, 11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINE (MK-801), A SUBSTANCE WITH POTENT ANTICONVULSANT, CENTRAL SYMPATHOMIMETIC, AND APPARENT ANXIOLYTIC PROPERTIES [J]. DRUG DEVELOPMENT RESEARCH, 1982, 2 (02) : 123 - 134

[6] COTMAN CW, 1987, TRENDS NEUROSCI, V10

[7] DUVERGER D, 1987, J CEREB BLOOD FLOW S, V7, pS144

[8] FOSTER A C, 1987, British Journal of Pharmacology, V90, p9P

[9] SYSTEMIC ADMINISTRATION OF MK-801 PREVENTS N-METHYL-D-ASPARTATE-INDUCED NEURONAL DEGENERATION IN RAT-BRAIN [J]. NEUROSCIENCE LETTERS, 1987, 76 (03) : 307 - 311

[10] FOSTER AC, IN PRESS SOC NEUR AB

[1] BENEVISTE H, 1984, J NEUROCHEM, V43, P1369

[2] BLOCK GA, 1987, J CEREB BLOOD FLOW M, V7, pS149

[3] BRIERLEY JB, 1984, GREENFIELDS NEUROPAT, P125

[4] CHOI D W, 1986, Society for Neuroscience Abstracts, V12, P381

[5] ANTICONVULSANT ACTIVITY OF (+)-5-METHYL-10, 11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINE (MK-801), A SUBSTANCE WITH POTENT ANTICONVULSANT, CENTRAL SYMPATHOMIMETIC, AND APPARENT ANXIOLYTIC PROPERTIES [J]. DRUG DEVELOPMENT RESEARCH, 1982, 2 (02) : 123 - 134

[6] COTMAN CW, 1987, TRENDS NEUROSCI, V10

[7] DUVERGER D, 1987, J CEREB BLOOD FLOW S, V7, pS144

[8] FOSTER A C, 1987, British Journal of Pharmacology, V90, p9P

[9] SYSTEMIC ADMINISTRATION OF MK-801 PREVENTS N-METHYL-D-ASPARTATE-INDUCED NEURONAL DEGENERATION IN RAT-BRAIN [J]. NEUROSCIENCE LETTERS, 1987, 76 (03) : 307 - 311

[10] FOSTER AC, IN PRESS SOC NEUR AB